Form D · Biotechnology
Cytobyte, Inc.
Cleveland, OH · CIK 0001676120
Offering snapshot reported Jun 2, 2016 · SEC filing
- Reported sold
- $0 Offering amount: $1.81M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $42K Reported outside-investor minimum
- First sale
- May 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2016 | Initial | $0 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $90.3K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-264288
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| McDonald Partners, LLC | 135414 | McDonald Partners, LLC · CRD 135414 |
Source: Form D, filed Jun 2, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jacob Glenn | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1111 Superior Ave. Suite 1110
Cleveland, OH, 44114
Cleveland, OH, 44114